The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19
Clinical trial NCT04347915 · COMPLETED
Trial details
- NCT number
- NCT04347915
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2021-02-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.